Monopar Therapeutics MNPR Operating Lease Liabilities (Total)
Operating Lease Liabilities (Total) at other companies
Other financials
Where this comes from
Reported directly by Monopar Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiability.
The official record: Monopar Therapeutics’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Monopar Therapeutics's operating lease liabilities (total).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Monopar Therapeutics's operating lease liabilities (total)?
- Monopar Therapeutics (MNPR) reported operating lease liabilities (total) of $230.43K in Q1 2026.
- How has Monopar Therapeutics's operating lease liabilities (total) changed year-over-year?
- Monopar Therapeutics's operating lease liabilities (total) increased by 2692.4% year-over-year, from $8.25K to $230.43K.
- What does operating lease liabilities (total) mean?
- This represents the total present value of future lease payments for operating leases, recognized as a liability on the balance sheet. It reflects the company's long-term commitment to leased assets such as office space, warehouses, and equipment. Tracking this helps investors evaluate the company's off-balance-sheet financing obligations and overall debt-like commitments.